Читать книгу Randomised Clinical Trials - David Machin - Страница 127
Example 3.24 Protocol SQGL02 (1999): Brimonidine as a neuroprotective agent in acute angle‐closure glaucoma
ОглавлениеThe right of the patient to refuse to participate without giving reasons must be respected. After the patient has entered the trial the clinician must remain free to give alternative treatment to that specified in the protocol at any stage if he/she feels it to be in the patient’s best interest. However, the reasons for doing so should be recorded and the patient will undergo an early termination visit for the purpose of follow‐up and data analysis. Similarly, the patient must remain free to withdraw at any time from protocol treatment without giving reasons and without prejudicing his/her further treatment.